Status:
UNKNOWN
Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function
Lead Sponsor:
Rabin Medical Center
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function
Eligibility Criteria
Inclusion
- Ischemic heart disease
- Systolic lv dysfunction
- Mild anemia
- Normal renal function
- Stable condition
Exclusion
- Pregnancy
- Unstable condition
- Under 18 years old
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
January 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00418119
Start Date
January 1 2007
End Date
January 1 2008
Last Update
January 4 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Department, Rabin Medical Center
Petah Tikva, Petah Tikva, Israel, 49100